According to Biolife Solutions 's latest financial reports the company's current revenue (TTM) is $0.14 B. In 2022 the company made a revenue of $0.16 B an increase over the years 2021 revenue that were of $0.11 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.14 B | -11.43% |
2022 | $0.16 B | 35.75% |
2021 | $0.11 B | 147.79% |
2020 | $48.08 M | 75.69% |
2019 | $27.37 M | 38.64% |
2018 | $19.74 M | 79.12% |
2017 | $11.02 M | 33.97% |
2016 | $8.22 M | 27.57% |
2015 | $6.44 M | 4.17% |
2014 | $6.19 M | -30.83% |
2013 | $8.94 M | 58.03% |
2012 | $5.66 M | 105.28% |
2011 | $2.75 M | 32.53% |
2010 | $2.08 M | 31.61% |
2009 | $1.58 M | 19.59% |
2008 | $1.32 M | 36.02% |
2007 | $0.97 M | 61.18% |
2006 | $0.6 M | -1.87% |
2005 | $0.61 M | -1.91% |
2004 | $0.62 M | 3.5% |
2003 | $0.6 M | -23.24% |
2002 | $0.78 M | -16.75% |
2001 | $0.94 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Celanese CE | $10.94 B | 7,535.83% | ๐บ๐ธ USA |
Enanta Pharmaceuticals
ENTA | $73.62 M | -48.61% | ๐บ๐ธ USA |
Amyris AMRS | $0.26 B | 87.21% | ๐บ๐ธ USA |